This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This AGTRAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 133-159 amino acids from the C-terminal region of human AGTRAP.
AGTRAP
Reaktivität: Human
ELISA
Wirt: Kaninchen
Polyclonal
HRP
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
AGTRAP
(Angiotensin II Receptor-Associated Protein (AGTRAP))
AGTRAP antikoerper, DKFZp469M235 antikoerper, LOC100223570 antikoerper, ATRAP antikoerper, 3300002E14Rik antikoerper, AT1R antikoerper, Atrap antikoerper, D4Wsu124e antikoerper, angiotensin II receptor associated protein antikoerper, angiotensin II receptor-associated protein antikoerper, angiotensin II, type I receptor-associated protein antikoerper, AGTRAP antikoerper, Agtrap antikoerper
Hintergrund
This gene encodes a transmembrane protein localized to the plasma membrane and perinuclear vesicular structures. The gene product interacts with the angiotensin II type I receptor and negatively regulates angiotensin II signaling. Alternative splicing of this gene generates multiple transcript variants encoding different isoforms.